1848-40-4 Usage
Uses
Used in Pharmaceutical and Agrochemical Industries:
1,2-Dihydro-2-methyl-3H-indazol-3-one is used as a reactant in the synthesis of various pharmaceutical and agrochemical compounds due to its chemical reactivity and structural properties that can be incorporated into a range of molecules with therapeutic or pesticidal potential.
Used in Medicinal Chemistry Research:
DIMIO is used as a subject of study in medicinal chemistry for its potential biological and pharmacological properties. Researchers are interested in its ability to inhibit certain enzymes, which could lead to the development of new drugs targeting specific biochemical pathways.
Used in Drug Discovery:
In the field of drug discovery, 1,2-Dihydro-2-methyl-3H-indazol-3-one is used as a starting point for the development of new therapeutic agents. Its potential as an anticancer agent is of particular interest, as it may contribute to the creation of novel cancer treatments by targeting specific cellular mechanisms.
Check Digit Verification of cas no
The CAS Registry Mumber 1848-40-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,8,4 and 8 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1848-40:
(6*1)+(5*8)+(4*4)+(3*8)+(2*4)+(1*0)=94
94 % 10 = 4
So 1848-40-4 is a valid CAS Registry Number.
1848-40-4Relevant academic research and scientific papers
Synthesis, biological evaluation and chemometric analysis of indazole derivatives. 1,2-Disubstituted 5-nitroindazolinones, new prototypes of antichagasic drug
Vega, María Celeste,Rolón, Miriam,Montero-Torres, Alina,Fonseca-Berzal, Cristina,Escario, José Antonio,Gómez-Barrio, Alicia,Gálvez, Jorge,Marrero-Ponce, Yovani,Arán, Vicente J.
, p. 214 - 227 (2013/02/23)
Chagas disease chemotherapy, currently based on only two drugs, nifurtimox and benznidazole, is far from satisfactory and therefore the development of new antichagasic compounds remains an important goal. On the basis of antichagasic properties previously
Hypolipidemic Activity of Phthalimide Derivatives. 7. Structure-Activity Studies of Indazolone Analogues
Wyrick, Steven D.,Voorstad, P. Josee,Cocolas, George,Hall, Iris H.
, p. 768 - 772 (2007/10/02)
The apparent benefit of limiting serum cholesterol and triglyceride levels either by dietary restriction or drug therapy has prompted work in our laboratories toward development of a suitable antihyperlipidemic agent.We have demonstrated the antihyperlipi